Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1992-2-10
pubmed:abstractText
The present studies were undertaken to determine whether lipolysis was increased in non-insulin-dependent diabetes mellitus (NIDDM) and, if so, to assess the influence of increased glycerol availability on its conversion to glucose and its contribution to the increased gluconeogenesis found in this condition. For this purpose, we infused nine subjects with NIDDM and 16 age-, weight-matched nondiabetic volunteers with [2-3H] glucose and [U-14C] glycerol and measured their rates of glucose and glycerol appearance in plasma and their rates of glycerol incorporation into plasma glucose. The rate of glycerol appearance, an index of lipolysis, was increased 1.5-fold in NIDDM subjects (2.85 +/- 0.16 vs. 1.62 +/- 0.08 mumol/kg per min, P less than 0.001). Glycerol incorporation into plasma glucose was increased threefold in NIDDM subjects (1.13 +/- 1.10 vs. 0.36 +/- 0.02 mumol/kg per min, P less than 0.01) and accounted for twice as much of hepatic glucose output (6.0 +/- 0.5 vs. 3.0 +/- 0.2%, P less than 0.001). Moreover, the percent of glycerol turnover used for gluconeogenesis (77 +/- 6 vs. 44 +/- 2, P less than 0.001) was increased in NIDDM subjects and, for a given plasma glycerol concentration, glycerol gluconeogenesis was increased more than two-fold. The only experimental variable significantly correlated with the increased glycerol gluconeogenesis after taking glycerol availability into consideration was the plasma free fatty acid concentration (r = 0.80, P less than 0.01). We, therefore, conclude that lipolysis is increased in NIDDM and, although more glycerol is thus available, increased activity of the intrahepatic pathway for conversion of glycerol into glucose, due at least in part to increased plasma free fatty acids, is the predominant mechanism responsible for enhanced glycerol gluconeogenesis. Finally, although gluconeogenesis from glycerol in NIDDM is comparable to that of alanine and about one-fourth that of lactate is terms of overall flux into glucose, glycerol is probably the most important gluconeogenic precursor in NIDDM in terms of adding new carbons to the glucose pool.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-13412685, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-13996476, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-2240206, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-2254458, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-2653926, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-2661589, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-2708210, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-3048115, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-3275857, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-3307452, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-3357420, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-3533681, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-3596563, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-3897287, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-4353268, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-4381783, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-4527190, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-4655498, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-4655970, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-4986215, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-5024045, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-5320561, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-5325046, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-5410103, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-6103495, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-6289809, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-6300941, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-6347772, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-6458521, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-6776842, http://linkedlifedata.com/resource/pubmed/commentcorrection/1729269-7022106
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
169-75
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.
pubmed:affiliation
Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania 15261.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't